The use of LMWH in pregnancies at risk: new evidence or perception?
Open Access
- 4 April 2005
- journal article
- Published by Wiley in Journal of Thrombosis and Haemostasis
- Vol. 3 (4) , 788-789
- https://doi.org/10.1111/j.1538-7836.2005.01288.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Aspirin or anticoagulants for the treatment of recurrent miscarriage in women without antiphospholipid syndromePublished by Wiley ,2005
- The long and winding road ... towards LMWH for pregnancy lossJournal of Thrombosis and Haemostasis, 2005
- Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?Journal of Thrombosis and Haemostasis, 2005
- Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE‐ENOX studyJournal of Thrombosis and Haemostasis, 2004
- Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT StatementAnnals of Internal Medicine, 2004
- Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – NoJournal of Thrombosis and Haemostasis, 2003
- High rate of skin complications due to low-molecular-weight heparins in pregnant womenJournal of Thrombosis and Haemostasis, 2003